Stocks · News reference

8-K filing — MEDIFAST INC (MED)

Jul 17, 2026, 12:33 PMSEC EDGAR

Filed: 2026-07-17 AccNo: 0001628280-26-048574 Size: 190 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 3, 2026, 9:05 PMBenzinga Insights
11 Consumer Staples Stocks Moving In Monday's After-Market Session
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today.
Read original at benzinga
ANDE BRCC DDC EDBL FAMI
BenzingaAug 3, 2026, 8:41 PMBenzinga Newsdesk
Medifast shares are trading higher after the company reported better-than-expected Q2 financial results.
Read original at benzinga
MED
BenzingaAug 3, 2026, 8:14 PMBenzinga Newsdesk
Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M Est
Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees sales of $60.000 million-$80.000 million vs $67.700 million analyst estimate.
Read original at benzinga
MED
SEC EDGARAug 3, 2026, 8:12 PMSEC EDGAR
8-K filing — MEDIFAST INC (MED)
Filed: 2026-08-03 AccNo: 0001628280-26-051845 Size: 301 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar
MED